Frederic Mazurier
Rennes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Therapeutic potential of antisense oligonucleotides in hematological malignancies.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 04, 2026
Molecularly targeted therapy and immunotherapy in leukemias.
Journal: Journal of hematology & oncology
Published: August 26, 2025
CD9, a tetraspanin in cancer: biology and therapeutic promise in acute leukemia.
Journal: Oncogenesis
Published: July 25, 2025
Diphenyleneiodonium Triggers Cell Death of Acute Myeloid Leukemia Cells by Blocking the Mitochondrial Respiratory Chain, and Synergizes with Cytarabine.
Journal: Cancers
Published: December 07, 2021
XPC multifaceted roles beyond DNA damage repair: p53-dependent and p53-independent functions of XPC in cell fate decisions.
Journal: Mutation research. Reviews in mutation research
Published: April 25, 2021
Targeting Reactive Oxygen Species Metabolism to Induce Myeloma Cell Death.
Journal: Cancers
Published: April 02, 2021
Characterization of NADPH Oxidase Expression and Activity in Acute Myeloid Leukemia Cell Lines: A Correlation with the Differentiation Status.
Journal: Antioxidants (Basel, Switzerland)
Published: February 07, 2021
VAS3947 Induces UPR-Mediated Apoptosis through Cysteine Thiol Alkylation in AML Cell Lines.
Journal: International journal of molecular sciences
Published: July 01, 2020
Hypoxia favors chemoresistance in T-ALL through an HIF1α-mediated mTORC1 inhibition loop.
Journal: Blood advances
Published: June 30, 2020
Differentiated Cells in Prolonged Hypoxia Produce Highly Infectious Native-Like Hepatitis C Virus Particles.
Journal: Hepatology (Baltimore, Md.)
Published: June 08, 2020
Repurposing of Acriflavine to Target Chronic Myeloid Leukemia Treatment.
Journal: Current medicinal chemistry
Published: May 28, 2020
Last Updated: 09/26/2026